Travere Therapeutics TVTX

$ 26.96 -1.28%

Annual report 2025
added 02-19-2026

Country	USA
IPO year	-
Industry	-
Stock Exchange	NASDAQ GLOBAL

Shares	89.2 M
Market Cap^[1]	$ 2.41 B
EBITDA (LTM)	$ -132 M
P/E (LTM)	-12.27
P/S (LTM)	7.76
EPS (LTM)	-2.22

References

Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.